Allogene Therapeutics Inc...

NASDAQ: ALLO · Real-Time Price · USD
1.09
-0.02 (-1.80%)
At close: May 22, 2025, 3:59 PM
1.09
-0.45%
After-hours: May 22, 2025, 07:33 PM EDT

Allogene Therapeutics Revenue Breakdown

Period Ending Dec 31, 2024
License Revenue 4.6M
License Revenue Growth n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017
Selling, General, and Administrative Revenue 14.99M 15.52M 16.33M 16.09M 17.27M 17.22M 17.04M 18.52M 18.88M 21M 18.9M 19.51M 19.9M 19.96M 19M 18.78M 16.36M 17.13M 16.62M 15.86M 15.64M 15.21M 15.02M 14.19M 13.06M 14.54M 11.32M 12.53M 2.6M 2K
Selling, General, and Administrative Revenue Growth -3.40% -4.99% +1.53% -6.83% +0.25% +1.07% -8.01% -1.91% -10.08% +11.14% -3.14% -1.95% -0.32% +5.06% +1.15% +14.79% -4.50% +3.10% +4.77% +1.41% +2.82% +1.31% +5.84% +8.65% -10.20% +28.50% -9.65% +382.33% +129750.00% n/a
Research and Development Revenue 50.2M 44.97M 44.71M 50.35M 52.26M 54.66M 45.98M 62.04M 80.24M 75.42M 63.64M 57.17M 60.16M 53.98M 58.72M 52.29M 55.18M 52.23M 51.42M 47.3M 42.04M 49.36M 39.99M 31.77M 23.4M 18.5M 10.87M 122.49M n/a n/a
Research and Development Revenue Growth +11.63% +0.58% -11.20% -3.64% -4.39% +18.89% -25.89% -22.68% +6.39% +18.51% +11.32% -4.96% +11.44% -8.07% +12.30% -5.24% +5.66% +1.57% +8.72% +12.50% -14.83% +23.42% +25.87% +35.77% +26.48% +70.23% -91.13% n/a n/a n/a